Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. K.C. Pharmaceuticals, Inc
FDA Inspection
•K.C. Pharmaceuticals, Inc•February 14, 2011

K.C. Pharmaceuticals, Inc – FDA Inspection, Feb 14, 2011

Record Details

This FDA Inspection record concerns K.C. Pharmaceuticals, Inc, with an inspection on February 14, 2011, issued by the Center for Devices and Radiological Health, covering devices.

Company
K.C. Pharmaceuticals, Inc
Inspection Date
February 14, 2011
Product Type
Devices
Office
Center for Devices and Radiological Health
View Company Profile

ID · 5fa2190c-0676-490a-aa8f-ac4801f1232c

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
711197
FDA center
Medical Devices & Rad Health
Project area
Compliance: Devices

FDA Citations

11
  1. 21 CFR 211.22(b)Adequate lab facilities not available
  2. 21 CFR 803.50(a)(1)Report of Death or Serious Injury
  3. 21 CFR 211.25(a)Training , Education , Experience overall
  4. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  5. 21 CFR 211.63Equipment Design, Size and Location
  6. 21 CFR 211.84(e)Rejecting When Specifications Not Met
  7. 21 CFR 820.100(a)Lack of or inadequate procedures
  8. 21 CFR 211.170(b)Annual visual exams of drug products
  9. 21 CFR 211.192Investigations of discrepancies, failures
  10. 21 CFR 211.22(d)Procedures not in writing, fully followed

Showing 10 of 11 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of K.C. Pharmaceuticals, Inc

10
DateClassificationOfficeProject area
February 13, 2026Not classifiedLos Angeles District OfficeDrug Quality Assurance
August 28, 2024VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 13, 2023OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 30, 2020VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 16, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 10 other inspections on the company page
Other documents for K.C. Pharmaceuticals, Inc
  • FDA Inspection 1294070 - 2026-02-13
  • FDA Inspection 1247201 - 2024-08-28
  • FDA Inspection 1197242 - 2023-02-13
  • FDA Inspection 1116341 - 2020-01-30
  • FDA Inspection 1032267 - 2017-11-16

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore K.C. Pharmaceuticals, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.